NCT05685745 Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
| NCT ID | NCT05685745 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Infant, Extremely Premature |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2019-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation at participating hospitals.
Eligibility Criteria
Inclusion Criteria: * All local births with gestational ages of 22 weeks 0 days - 23 weeks 6 days, regardless of pregnancy outcome or neonatal intensive care (NICU) admission; AND * All outborn NICU admissions with gestational age at birth of 22 weeks 0 days - 23 weeks 6 days * Optional: Centers who desire to include data for NICU admissions of infants born \<22 weeks' gestation may also submit these data.
Contact & Investigator
Matthew A Rysavy, MD, PhD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT05685745 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 1 Year, studying Infant, Extremely Premature. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05685745 currently recruiting?
Yes, NCT05685745 is actively recruiting participants. Contact the research team at Matthew.A.Rysavy@uth.tmc.edu for enrollment information.
Where is the NCT05685745 trial being conducted?
This trial is being conducted at Birmingham, United States, Mobile, United States, Phoenix, United States, Long Beach, United States and 11 additional locations.
Who is sponsoring the NCT05685745 clinical trial?
NCT05685745 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Matthew A Rysavy, MD, PhD at The University of Texas Health Science Center, Houston. The trial plans to enroll 5,000 participants.